Cited by 283Pluripotent Stem Cells ResearchGenetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index; 31 of the 42 sources its claims cite were checked for support.

Single-cell brain organoid screening identifies developmental defects in autism

Open access

Published version of a preprint

Abstract

The development of the human brain involves unique processes (not observed in many other species) that can contribute to neurodevelopmental disorders 1–4 . Cerebral organoids enable the study of neurodevelopmental disorders in a human context. We have developed the CRISPR–human organoids–single-cell RNA sequencing (CHOOSE) system, which uses verified pairs of guide RNAs, inducible CRISPR–Cas9-based genetic disruption and single-cell transcriptomics for pooled loss-of-function screening in mosaic organoids. Here we show that perturbation of 36 high-risk autism spectrum disorder genes related to transcriptional regulation uncovers their effects on cell fate determination. We find that dorsal intermediate progenitors, ventral progenitors and upper-layer excitatory neurons are among the most vulnerable cell types. We construct a developmental gene regulatory network of cerebral organoids from single-cell transcriptomes and chromatin modalities and identify autism spectrum disorder-associated and perturbation-enriched regulatory modules. Perturbing members of the BRG1/BRM-associated factor (BAF) chromatin remodelling complex leads to enrichment of ventral telencephalon progenitors. Specifically, mutating the BAF subunit ARID1B affects the fate transition of progenitors to oligodendrocyte and interneuron precursor cells, a phenotype that we confirmed in patient-specific induced pluripotent stem cell-derived organoids. Our study paves the way for high-throughput phenotypic characterization of disease susceptibility genes in organoid models with cell state, molecular pathway and gene regulatory network readouts.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

The authors developed CHOOSE, a pooled CRISPR–single-cell RNA sequencing system in mosaic human cerebral organoids, and used it to screen 36 high-risk autism spectrum disorder (ASD) genes for developmental loss-of-function phenotypes. They identify vulnerable progenitor and neuronal cell types, ASD-associated regulatory modules, and show that ARID1B perturbation expands ventral progenitors and shifts their fate toward early oligodendrocyte precursor cells, with validation in patient-derived organoids and prenatal MRI.

Key findings

  • Perturbation of 36 high-risk ASD genes affected cell fate: 24 perturbations significantly changed the dorsal-to-ventral cell ratio, with 21 of 24 lowering it; 23 perturbations changed abundance of at least one cell type (CMH test, FDR < 0.05).
  • IPC depletion was a convergent effect in 12 perturbations; v-RGC and/or ccv-RGC enrichment occurred in 10 perturbations; INP enrichment occurred in 10 perturbations; L2/3 excitatory neurons were depleted in the majority of perturbations.
  • Across perturbations, 2,071 differentially expressed genes were detected; top DEGs were significantly enriched in SFARI ASD risk genes (approximately twofold, Fisher exact test P < 10−5) but not in intellectual disability risk genes.
  • ARID1B perturbation enriched v-RGCs and increased their transition probability toward early OPCs (two-sided Wilcoxon P = 7.7 × 10−8); patient iPS cell-derived ventralized organoids showed increased OLIG2+, DLX2+ and DLX2+OLIG2+ cells, and prenatal MRI showed enlarged ganglionic eminence in an ARID1B-mutant patient.

Methods

  • CHOOSE combines barcoded dual sgRNA lentiviral libraries, inducible eCas9 in hES cells, and mosaic cerebral organoids; the screen targeted 36 SFARI score 1 ASD genes with verified sgRNA pairs.
  • Single-cell transcriptomics was performed on 4-month-old organoids: 49,754 cells in the full CHOOSE dataset, with 35,203 control/uninduced cells used for annotation; data came from 14 independent organoid pools, 3–7 organoids per pool, 65 organoids total, across three batches.
  • Analyses included differential gRNA representation, CMH-based differential abundance, differential expression, single-cell multiome-based GRN inference with Pando, CellRank fate mapping, immunohistochemistry, patient iPS cell-derived organoids, and fetal MRI with 3D reconstruction.

Limitations

  • The paper states the system lacks certain brain cell types such as microglia and does not include medial ganglionic eminence-derived interneurons.
  • The paper states it does not know whether perturbed cells are heterozygous or homozygous for each mutation, and that transient effects of ASD risk gene perturbations may not be captured.
  • The paper notes mutant cells remained at low percentages during development, averaging 21.8% on day 120, which could limit mutant cell–cell interactions within mosaic tissues.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06473-y

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The CHOOSE system for multiplexed screening of ASD risk genes in human cerebral organoids. a, CHOOSE system overview. Barcoded dual sgRNA cassette located within the 3′ LTR of the lentivirus. b, Reporter assay to test gRNA efficiencies for 36 ASD risk genes. c, Editing efficiencies of gRNAs determined by flow cytometry. Plots show examples of gRNAs with no or efficient editing. d, sgRNA sequence read distributions of gRNAs sequenced from the ASD plasmid library, lentivirus-infected hES cells and embryoid bodies at day 5. e, Numbers of clones from the starting hES cells for each perturbation used to generate mosaic cerebral organoids. Control, non-targeting gRNAs. f, UMAP embedding of the scRNA-seq dataset containing dorsal and ventral telencephalon trajectories. Subclustering and UMAP embedding of the ventral telencephalon trajectory excluding astrocytes and ccv-RGCs to annotate the OPC cluster. g, Heat map showing the expression of marker genes in different cell types. ccRGC, cycling radial glial cell; CThPN, cortical thalamic projection neuron; oRGC, outer radial glial cell; IDM, improved differentiation medium; NI, neural induction.
Fig. 1 The CHOOSE system for multiplexed screening of ASD risk genes in human cerebral organoids. a, CHOOSE system overview. Barcoded dual sgRNA cassette located within the 3′ LTR of the lentivirus. b, Reporter assay to test gRNA efficiencies for 36 ASD risk genes. c, Editing efficiencies of gRNAs determined by flow cytometry. Plots show examples of gRNAs with no or efficient editing. d, sgRNA sequence read distributions of gRNAs sequenced from the ASD plasmid library, lentivirus-infected hES cells and embryoid bodies at day 5. e, Numbers of clones from the starting hES cells for each perturbation used to generate mosaic cerebral organoids. Control, non-targeting gRNAs. f, UMAP embedding of the scRNA-seq dataset containing dorsal and ventral telencephalon trajectories. Subclustering and UMAP embedding of the ventral telencephalon trajectory excluding astrocytes and ccv-RGCs to annotate the OPC cluster. g, Heat map showing the expression of marker genes in different cell types. ccRGC, cycling radial glial cell; CThPN, cortical thalamic projection neuron; oRGC, outer radial glial cell; IDM, improved differentiation medium; NI, neural induction.CC BY · PubMed Central
Fig. 2 Cell type-specific effects of ASD risk gene perturbations. a, Box plot showing the representation of gRNAs in eCas9-induced and uninduced organoid pools (induced cells, n = 14 independent pools of organoids, three batches; uninduced cells, n = 8 independent pools of organoids, two batches). The centre lines represent the medians, the box limits show the 25–75% interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. b, Bar plot showing fold change of gRNA representation in eCas9-induced versus uninduced cell pools. c, Heat map showing enrichment of gRNAs versus control in dorsal versus ventral telencephalon (telen.) cells (left panel, orange to purple) and individual cell types (centre and right panels, red to blue). Colours indicate the log odds ratio, and sizes indicate −log10 FDR-corrected P values of a two-sided CMH test stratified by organoid pool.
Fig. 2 Cell type-specific effects of ASD risk gene perturbations. a, Box plot showing the representation of gRNAs in eCas9-induced and uninduced organoid pools (induced cells, n = 14 independent pools of organoids, three batches; uninduced cells, n = 8 independent pools of organoids, two batches). The centre lines represent the medians, the box limits show the 25–75% interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. b, Bar plot showing fold change of gRNA representation in eCas9-induced versus uninduced cell pools. c, Heat map showing enrichment of gRNAs versus control in dorsal versus ventral telencephalon (telen.) cells (left panel, orange to purple) and individual cell types (centre and right panels, red to blue). Colours indicate the log odds ratio, and sizes indicate −log10 FDR-corrected P values of a two-sided CMH test stratified by organoid pool.CC BY · PubMed Central
Fig. 3 Dysregulated gene expression and regulatory networks caused by perturbations of ASD risk genes. a, Jitter plots showing DEGs detected in dorsal and ventral trajectories from each genetic perturbation. b, Jitter plot shows the frequency of DEGs detected from all perturbations separated by dorsal (orange) and ventral (blue) trajectories. Points belonging to the same gene are connected with a grey line. c, Top biological pathways enriched for TOP-DEGs (top 30 DEGs per perturbation) identified from all perturbations. d, Enrichment test of TOP-DEGs per perturbation in ID (sysID database) or ASD (SFARI database) genes. Two-sided Fisher exact test, P = 3.8 × 10−7. e, GRN of 4-month-old cerebral organoids inferred by Pando showing developmental TF modules constructed on the basis of their coexpression and interaction strengths. ASD-associated TF modules are highlighted in yellow (SFARI genes) and/or black (regulator of SFARI genes). f, Lolliplots show CHOOSE DEG-enriched TF modules in dorsal and ventral trajectories. The x axis represents the sign of the log odds ratio multiplied by the −log10 FDR-corrected P value of a two-sided Fisher exact test (signed −log10 FDR). The dashed lines indicate an FDR of 0.05. g, Circular gene regulatory subnetwork plots show primary and secondary targets of OLIG1 and EOMES. ASD-specific TF modules are highlighted in black and yellow as described above. Blue edges indicate repressive connections, and red edges indicate activating connections. NPC, neural progenitor cell.
Fig. 3 Dysregulated gene expression and regulatory networks caused by perturbations of ASD risk genes. a, Jitter plots showing DEGs detected in dorsal and ventral trajectories from each genetic perturbation. b, Jitter plot shows the frequency of DEGs detected from all perturbations separated by dorsal (orange) and ventral (blue) trajectories. Points belonging to the same gene are connected with a grey line. c, Top biological pathways enriched for TOP-DEGs (top 30 DEGs per perturbation) identified from all perturbations. d, Enrichment test of TOP-DEGs per perturbation in ID (sysID database) or ASD (SFARI database) genes. Two-sided Fisher exact test, P = 3.8 × 10−7. e, GRN of 4-month-old cerebral organoids inferred by Pando showing developmental TF modules constructed on the basis of their coexpression and interaction strengths. ASD-associated TF modules are highlighted in yellow (SFARI genes) and/or black (regulator of SFARI genes). f, Lolliplots show CHOOSE DEG-enriched TF modules in dorsal and ventral trajectories. The x axis represents the sign of the log odds ratio multiplied by the −log10 FDR-corrected P value of a two-sided Fisher exact test (signed −log10 FDR). The dashed lines indicate an FDR of 0.05. g, Circular gene regulatory subnetwork plots show primary and secondary targets of OLIG1 and EOMES. ASD-specific TF modules are highlighted in black and yellow as described above. Blue edges indicate repressive connections, and red edges indicate activating connections. NPC, neural progenitor cell.CC BY · PubMed Central
Fig. 4 Perturbation of ARID1B increases the transition of v-RGCs to early OPCs. a, Circular projection of terminal fate probabilities shows ventral telencephalon differentiation trajectories. b, Trajectory branches defined by gene expressions of DLX2 (INP), DLX5 (IN), OLIG2 (early OPC) and PDGFRA (late OPC). c, Differential density of cells with ARID1B perturbation versus control. d, Bar graph shows cells within the v-RGCs that are positive for DLX2 (68.6 versus 81.5%), OLIG2 (19.6 versus 36.2%) and both (9.8 versus 30.6%) in control versus ARID1B perturbation. e, Box plots showing transition probabilities of control (n = 51) and ARID1B-perturbed (n = 46) ventral progenitor cells towards OPCs. The centre lines represent the medians, the box limits show the 25–75% interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. Two-sided Wilcoxon test P value = 7.7 × 10−8. f, Immunohistochemistry for early OPCs (OLIG2) and INPs (DLX2) of day 40 ventralized brain organoids derived from control (c.220dupG repair) and two ARID1B patient iPS cells. Scale bar, 200 μm. g, Violin plots (all data points and median values) show numbers of cells positive for OLIG2 and/or DLX2. Control, n = 108 areas from 13 organoids, four batches; ARID1B +/− (c.2201dupG), n = 104 areas from 15 organoids, four batches; ARID1B +/− (6q25.3del), n = 94 areas from 15 organoids, three batches. One-way analysis of variance (ANOVA) post hoc Tukey test; ***P < 0.001. h, Prenatal magnetic resonance imaging scan and 3D reconstruction of LGE and CGE (marked as GE) from age-matched controls and a patient with an ARID1B mutation showing enlarged GE in the patient (quantified in Extended Data Fig. 10). Scale bar, 1 cm. i, Diagram showing ARID1B perturbation-induced cellular responses of ventral progenitors. WT, wild type.
Fig. 4 Perturbation of ARID1B increases the transition of v-RGCs to early OPCs. a, Circular projection of terminal fate probabilities shows ventral telencephalon differentiation trajectories. b, Trajectory branches defined by gene expressions of DLX2 (INP), DLX5 (IN), OLIG2 (early OPC) and PDGFRA (late OPC). c, Differential density of cells with ARID1B perturbation versus control. d, Bar graph shows cells within the v-RGCs that are positive for DLX2 (68.6 versus 81.5%), OLIG2 (19.6 versus 36.2%) and both (9.8 versus 30.6%) in control versus ARID1B perturbation. e, Box plots showing transition probabilities of control (n = 51) and ARID1B-perturbed (n = 46) ventral progenitor cells towards OPCs. The centre lines represent the medians, the box limits show the 25–75% interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. Two-sided Wilcoxon test P value = 7.7 × 10−8. f, Immunohistochemistry for early OPCs (OLIG2) and INPs (DLX2) of day 40 ventralized brain organoids derived from control (c.220dupG repair) and two ARID1B patient iPS cells. Scale bar, 200 μm. g, Violin plots (all data points and median values) show numbers of cells positive for OLIG2 and/or DLX2. Control, n = 108 areas from 13 organoids, four batches; ARID1B +/− (c.2201dupG), n = 104 areas from 15 organoids, four batches; ARID1B +/− (6q25.3del), n = 94 areas from 15 organoids, three batches. One-way analysis of variance (ANOVA) post hoc Tukey test; ***P < 0.001. h, Prenatal magnetic resonance imaging scan and 3D reconstruction of LGE and CGE (marked as GE) from age-matched controls and a patient with an ARID1B mutation showing enlarged GE in the patient (quantified in Extended Data Fig. 10). Scale bar, 1 cm. i, Diagram showing ARID1B perturbation-induced cellular responses of ventral progenitors. WT, wild type.CC BY · PubMed Central
Extended Data Fig. 1 A gRNA reporter assay to determine gRNA efficiency. a, Diagram of the lentiviral construct delivering dual-sgRNA cassette and eCas9 under the spleen focus forming virus (SFFV) promotor. Lentivirus infected cells are labelled with GFP. Retroviral transduction is used to generate 3T3 cell lines. A pre-assembled array of gRNA-targeting sequences is fused with TagBFP. b, Flow cytometry graph shows a 3T3 reporter cell line is positive for both BFP and Tomato. After lentiviral infection, transduced cells (GFP+) and internal control cells (GFP-) are subjected to FACS-based analysis at 20 dpi. Efficient editing causing frameshift mutations lead to the loss of BFP fluorescence. c, Four dual-sgRNA examples show no (0–10% reduction), mild (10–45% reduction), medium (45–75% reduction) and strong editing efficiency (> 75% reduction) at 20 dpi, respectively, based on median fluorescence intensity. d, 98 pairs of gRNAs were tested and categorized into four groups. e, Editing efficiency of selected paired gRNAs from 36 ASD genes.
Extended Data Fig. 1 A gRNA reporter assay to determine gRNA efficiency. a, Diagram of the lentiviral construct delivering dual-sgRNA cassette and eCas9 under the spleen focus forming virus (SFFV) promotor. Lentivirus infected cells are labelled with GFP. Retroviral transduction is used to generate 3T3 cell lines. A pre-assembled array of gRNA-targeting sequences is fused with TagBFP. b, Flow cytometry graph shows a 3T3 reporter cell line is positive for both BFP and Tomato. After lentiviral infection, transduced cells (GFP+) and internal control cells (GFP-) are subjected to FACS-based analysis at 20 dpi. Efficient editing causing frameshift mutations lead to the loss of BFP fluorescence. c, Four dual-sgRNA examples show no (0–10% reduction), mild (10–45% reduction), medium (45–75% reduction) and strong editing efficiency (> 75% reduction) at 20 dpi, respectively, based on median fluorescence intensity. d, 98 pairs of gRNAs were tested and categorized into four groups. e, Editing efficiency of selected paired gRNAs from 36 ASD genes.CC BY · PubMed Central
Extended Data Fig. 2 Perturbations of ASD genes efficiently decrease protein expression levels. a, Confocal images showing IHC analyzes of protein expression levels in organoids with individual genes perturbed (ADNP, ARID1B, PHF3, SMARCC2, KMT2C). Note that both wild-type (dTomato-) and perturbed cells (dTomato+) present in each organoid. Arrowheads and dotted lines indicate perturbed cells or ventricular zones, respectively. b, Violin plots (all data points and median values; each data point represents a single cell; cells were measured from 4 organoids) showing quantification of protein expression levels, as measured by fluorescent intensity. Bar plot (mean ± S.D., n = 3 areas from 3 individual organoid) showing quantification of protein expression levels from eCas9-uninduced and induced VZ area. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 100 μm.
Extended Data Fig. 2 Perturbations of ASD genes efficiently decrease protein expression levels. a, Confocal images showing IHC analyzes of protein expression levels in organoids with individual genes perturbed (ADNP, ARID1B, PHF3, SMARCC2, KMT2C). Note that both wild-type (dTomato-) and perturbed cells (dTomato+) present in each organoid. Arrowheads and dotted lines indicate perturbed cells or ventricular zones, respectively. b, Violin plots (all data points and median values; each data point represents a single cell; cells were measured from 4 organoids) showing quantification of protein expression levels, as measured by fluorescent intensity. Bar plot (mean ± S.D., n = 3 areas from 3 individual organoid) showing quantification of protein expression levels from eCas9-uninduced and induced VZ area. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 100 μm.CC BY · PubMed Central
Extended Data Fig. 3 gRNA library, infection and integration of CHOOSE lentivirus in hES cells. a, Plot showing cumulative fraction of uniquely barcoded gRNA cassettes from the CHOOSE ASD plasmid library. b, Plot showing cumulative fraction of uniquely barcoded gRNA cassettes separated by each target gene from the plasmid library. c, Infection rate of CHOOSE lentivirus on hES cells determined by flow-cytometry. Infected cells are positive for GFP. d, Top diagram showing the duplication of the dual-sgRNA cassette after the lentiviral integration into the host genome. FW and RV are paired primers used to demonstrate the successful integration of the lentivirus. The primers amplify specific regions of the genomic DNA extracted from lentivirus-infected hES cells, and the lentiviral plasmid. e, Representative gel electrophoresis analysis from 2 independent experiments showing 12 kb and 13 kb bands detected from gDNA and plasmid respectively.
Extended Data Fig. 3 gRNA library, infection and integration of CHOOSE lentivirus in hES cells. a, Plot showing cumulative fraction of uniquely barcoded gRNA cassettes from the CHOOSE ASD plasmid library. b, Plot showing cumulative fraction of uniquely barcoded gRNA cassettes separated by each target gene from the plasmid library. c, Infection rate of CHOOSE lentivirus on hES cells determined by flow-cytometry. Infected cells are positive for GFP. d, Top diagram showing the duplication of the dual-sgRNA cassette after the lentiviral integration into the host genome. FW and RV are paired primers used to demonstrate the successful integration of the lentivirus. The primers amplify specific regions of the genomic DNA extracted from lentivirus-infected hES cells, and the lentiviral plasmid. e, Representative gel electrophoresis analysis from 2 independent experiments showing 12 kb and 13 kb bands detected from gDNA and plasmid respectively.CC BY · PubMed Central
Extended Data Fig. 4 Clonal diversity of the CHOOSE organoids. a,b, Reads distribution for each barcoded gRNA cassette from the plasmid library (a) and from genomic DNA (b) extracted from the hES cells infected by lentivirus. c, Box plot (minimum, maximum and median values; all data points) showing clone numbers recovered from scRNAseq libraries. Each data point represents a scRNAseq library. n = 11 independent pools (libraries) of organoids as replicates, 2 batches. d, Bar plot showing total clone numbers for each perturbation recovered from 11 scRNAseq libraries. e, Violin plot showing clone size distribution for each perturbation recovered from 11 scRNAseq libraries. Each data point represents one clone. f, Violin plot showing the average size of total clones recovered for each perturbation. g, h, Box plots (minimum, maximum and median values; all data points) showing the number of clones recovered from bulk genomic DNA extracted from eCas9-induced and uninduced cells. Each data point represents a bulk genomic DNA sample (50,000–150,000 cells sorted from pooled organoids). n = 5 pools of organoids for eCas9-induced cells; n = 11 pools of organoids for eCas9-uninduced cells. UCB, unique clone barcode.
Extended Data Fig. 4 Clonal diversity of the CHOOSE organoids. a,b, Reads distribution for each barcoded gRNA cassette from the plasmid library (a) and from genomic DNA (b) extracted from the hES cells infected by lentivirus. c, Box plot (minimum, maximum and median values; all data points) showing clone numbers recovered from scRNAseq libraries. Each data point represents a scRNAseq library. n = 11 independent pools (libraries) of organoids as replicates, 2 batches. d, Bar plot showing total clone numbers for each perturbation recovered from 11 scRNAseq libraries. e, Violin plot showing clone size distribution for each perturbation recovered from 11 scRNAseq libraries. Each data point represents one clone. f, Violin plot showing the average size of total clones recovered for each perturbation. g, h, Box plots (minimum, maximum and median values; all data points) showing the number of clones recovered from bulk genomic DNA extracted from eCas9-induced and uninduced cells. Each data point represents a bulk genomic DNA sample (50,000–150,000 cells sorted from pooled organoids). n = 5 pools of organoids for eCas9-induced cells; n = 11 pools of organoids for eCas9-uninduced cells. UCB, unique clone barcode.CC BY · PubMed Central
Extended Data Fig. 5 Generation of cerebral organoids using the CHOOSE system. a, Schematic showing the protocol used for generating cerebral organoids. 4-OHT was added to induce eCas9 expression at day 5. A short 3-day CHIR treatment was applied from day 12–14. Culture medium was switched to Brainphys after day 60 for advanced neuronal maturation. Tissues are collected at day 120 and subjected to scRNA-seq assays. b, ES cells were infected by lentivirus and GFP positive cells were collected to make EBs. Microscopic images show the overall morphology and GFP expression of cerebral organoids overtime. Top, bright-field; Bottom, GFP fluorescence. Scale bar, 100 μm. c. Immunohistochemical staining of cerebral organoids on day 24. GFP labels cells infected with lentivirus and Tomato is a reporter for eCas9 expression. SOX2 is a marker for progenitor cells. FOXG1 is a marker for tissues with telencephalon identity. d, FACS plots showing percentages of eCas9-induced cell population (GFP+/dTomato+) at day 30. Organoids are treated with different concentrations of 4-OHT at day 5. e, FACS plots showing percentages of eCas9-induced cell population at different developmental stages when organoids are treated with 0.3 ug/ml 4-OHT. f, Bar plot (mean ± S.D.) showing average eCas9 induction rate at day 120 when organoids are treated with 0.3 ug/ml 4-OHT. Each dot indicates a pool of 3–7 organoids. n = 9 biologically independent pools of organoids, examined over 2 independent experimental batches. Data are presented as mean values ± SD.
Extended Data Fig. 5 Generation of cerebral organoids using the CHOOSE system. a, Schematic showing the protocol used for generating cerebral organoids. 4-OHT was added to induce eCas9 expression at day 5. A short 3-day CHIR treatment was applied from day 12–14. Culture medium was switched to Brainphys after day 60 for advanced neuronal maturation. Tissues are collected at day 120 and subjected to scRNA-seq assays. b, ES cells were infected by lentivirus and GFP positive cells were collected to make EBs. Microscopic images show the overall morphology and GFP expression of cerebral organoids overtime. Top, bright-field; Bottom, GFP fluorescence. Scale bar, 100 μm. c. Immunohistochemical staining of cerebral organoids on day 24. GFP labels cells infected with lentivirus and Tomato is a reporter for eCas9 expression. SOX2 is a marker for progenitor cells. FOXG1 is a marker for tissues with telencephalon identity. d, FACS plots showing percentages of eCas9-induced cell population (GFP+/dTomato+) at day 30. Organoids are treated with different concentrations of 4-OHT at day 5. e, FACS plots showing percentages of eCas9-induced cell population at different developmental stages when organoids are treated with 0.3 ug/ml 4-OHT. f, Bar plot (mean ± S.D.) showing average eCas9 induction rate at day 120 when organoids are treated with 0.3 ug/ml 4-OHT. Each dot indicates a pool of 3–7 organoids. n = 9 biologically independent pools of organoids, examined over 2 independent experimental batches. Data are presented as mean values ± SD.CC BY · PubMed Central
Extended Data Fig. 6 Cell type and gRNA composition of scRNA-seq libraries. a, Histograms showing UMI count and number of detected features in the QC-controlled scRNA-seq dataset for each batch of organoids. b, Bar plot showing numbers of recovered cells with assigned gRNAs for each library. c, Bar plots showing cell number and gRNA composition for each replicate split by batch. d, UMAP embedding of unperturbed cells (control gRNA and eCas9-uninduced) coloured by annotated cell type. e,f,h,i, UMAP embedding of the unperturbed cells and full CHOOSE dataset including induced and uninduced samples filtered for gRNA detection. Cells are coloured by perturbation status (e,h) and batch (f,i). g,j, Feature plots showing expression of marker genes on a UMAP embedding for unperturbed cells (g) and full CHOOSE dataset (j). k, UMAP embedding coloured by velocity pseudotime to show developmental directions. l,m, Heatmaps showing expression of perturbed target genes in cerebral organoid cell types (l) and cell types in the developing human brain (Braun et al.32) (m).
Extended Data Fig. 6 Cell type and gRNA composition of scRNA-seq libraries. a, Histograms showing UMI count and number of detected features in the QC-controlled scRNA-seq dataset for each batch of organoids. b, Bar plot showing numbers of recovered cells with assigned gRNAs for each library. c, Bar plots showing cell number and gRNA composition for each replicate split by batch. d, UMAP embedding of unperturbed cells (control gRNA and eCas9-uninduced) coloured by annotated cell type. e,f,h,i, UMAP embedding of the unperturbed cells and full CHOOSE dataset including induced and uninduced samples filtered for gRNA detection. Cells are coloured by perturbation status (e,h) and batch (f,i). g,j, Feature plots showing expression of marker genes on a UMAP embedding for unperturbed cells (g) and full CHOOSE dataset (j). k, UMAP embedding coloured by velocity pseudotime to show developmental directions. l,m, Heatmaps showing expression of perturbed target genes in cerebral organoid cell types (l) and cell types in the developing human brain (Braun et al.32) (m).CC BY · PubMed Central
Extended Data Fig. 7 gRNA representation in eCas9-induced and uninduced cell populations of the CHOOSE organoids. a, Bar plots showing gRNA representation in scRNAseq libraries (pink circle; each library is an independent pool of organoids) and in bulk genomic DNA extracted from eCas9-induced and uninduced cell populations (blue circle; each sample is sorted from an independent pool of organoids) at 4 months. The numbers within each circle indicate batch numbers. Note batch 3 does not include non-targeting gRNA control and uses internal eCas9-uninduced cells as an alternative control. b, Bar plot showing gRNA representation in bulk genomic DNA extracted from eCas9-induced and uninduced cell populations sorted from organoid pools at different development stages.
Extended Data Fig. 7 gRNA representation in eCas9-induced and uninduced cell populations of the CHOOSE organoids. a, Bar plots showing gRNA representation in scRNAseq libraries (pink circle; each library is an independent pool of organoids) and in bulk genomic DNA extracted from eCas9-induced and uninduced cell populations (blue circle; each sample is sorted from an independent pool of organoids) at 4 months. The numbers within each circle indicate batch numbers. Note batch 3 does not include non-targeting gRNA control and uses internal eCas9-uninduced cells as an alternative control. b, Bar plot showing gRNA representation in bulk genomic DNA extracted from eCas9-induced and uninduced cell populations sorted from organoid pools at different development stages.CC BY · PubMed Central
Extended Data Fig. 8 Perturbations of ASD risk genes lead to cell proliferation or depletion. a, Schematic showing organoids perturbed with individual genes are subjected to phenotypic characterizations through FACS and IHC analyzes. Note that wild-type (eCas9-) and perturbed (eCas9+) cells present in each organoid. b, c, Bar plots (mean ± S.D., n = 3 (b) or 5 (c) biologically independent pools, each pool contains 3 organoids) showing perturbation-induced over-proliferation (KMT2C and LEO1) and depletion (ADNP and WAC). Over-proliferation and depletion were calculated using the number of induced cells divided by the number of un-induced cells sorted from the same pool of organoids, and compared to non-targeting gRNA control. One-way ANOVA post hoc Fisher’s LSD test. *P < 0.05, **P < 0.01. d, Confocal images showing representative images of organoids with individual genes perturbed. IHC analyzes were performed on 60-day-old organoids from at least 4 organoids over two independent batches. GFP labels cells expressing gRNA construct and dTomato indicates the induction of eCas9. Scale bar, 200 μm.
Extended Data Fig. 8 Perturbations of ASD risk genes lead to cell proliferation or depletion. a, Schematic showing organoids perturbed with individual genes are subjected to phenotypic characterizations through FACS and IHC analyzes. Note that wild-type (eCas9-) and perturbed (eCas9+) cells present in each organoid. b, c, Bar plots (mean ± S.D., n = 3 (b) or 5 (c) biologically independent pools, each pool contains 3 organoids) showing perturbation-induced over-proliferation (KMT2C and LEO1) and depletion (ADNP and WAC). Over-proliferation and depletion were calculated using the number of induced cells divided by the number of un-induced cells sorted from the same pool of organoids, and compared to non-targeting gRNA control. One-way ANOVA post hoc Fisher’s LSD test. *P < 0.05, **P < 0.01. d, Confocal images showing representative images of organoids with individual genes perturbed. IHC analyzes were performed on 60-day-old organoids from at least 4 organoids over two independent batches. GFP labels cells expressing gRNA construct and dTomato indicates the induction of eCas9. Scale bar, 200 μm.CC BY · PubMed Central
Extended Data Fig. 9 Cell type compositional changes caused by ASD gene perturbations. a, UMAP embeddings show single cell distribution for each perturbed gene. Local cell composition differences of perturbation versus control indicated by red (enrichment) or blue (depletion). b, UMAP embedding of the scRNA-seq dataset containing dorsal and ventral telencephalon trajectories.
Extended Data Fig. 9 Cell type compositional changes caused by ASD gene perturbations. a, UMAP embeddings show single cell distribution for each perturbed gene. Local cell composition differences of perturbation versus control indicated by red (enrichment) or blue (depletion). b, UMAP embedding of the scRNA-seq dataset containing dorsal and ventral telencephalon trajectories.CC BY · PubMed Central
Extended Data Fig. 10 Differential abundance effects of perturbations across independent pools of organoids. Lolliplots showing effect size of differential abundance (log odds ratio) per cell type and target gene. Dot colour indicates batch, size indicates number of cells. A t-test was performed against a permuted background distribution to highlight highly consistent effects across replicates. Stars indicate statistical significance in the single cell-level test, diamonds indicate significance of a two-sided t-test across pools of organoids (P < 0.05).
Extended Data Fig. 10 Differential abundance effects of perturbations across independent pools of organoids. Lolliplots showing effect size of differential abundance (log odds ratio) per cell type and target gene. Dot colour indicates batch, size indicates number of cells. A t-test was performed against a permuted background distribution to highlight highly consistent effects across replicates. Stars indicate statistical significance in the single cell-level test, diamonds indicate significance of a two-sided t-test across pools of organoids (P < 0.05).CC BY · PubMed Central
Extended Data Fig. 11 Perturbations of ASD risk genes lead to depletion of IPs. a-d, Confocal images showing immunohistochemical staining of EOMES on 60-day-old organoids perturbed with individual genes. dTomato labels eCas9-induced cells. Yellow box labels radially organized structure with ventricular zone (VZ), subventricular zone (SVZ) and cortical plate (CP). Note the presence of EOMES+ cells in the SVZ. e, Bar plot (mean ± S.E.M.; all data points; from left to right, n = 14, 14, 14, 12 areas collected from 4 organoids for each perturbation) showing quantification of percent EOMES+ cells per eCas9 positive column area. Individual perturbations are compared to non-targeting gRNA control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 100 μm.
Extended Data Fig. 11 Perturbations of ASD risk genes lead to depletion of IPs. a-d, Confocal images showing immunohistochemical staining of EOMES on 60-day-old organoids perturbed with individual genes. dTomato labels eCas9-induced cells. Yellow box labels radially organized structure with ventricular zone (VZ), subventricular zone (SVZ) and cortical plate (CP). Note the presence of EOMES+ cells in the SVZ. e, Bar plot (mean ± S.E.M.; all data points; from left to right, n = 14, 14, 14, 12 areas collected from 4 organoids for each perturbation) showing quantification of percent EOMES+ cells per eCas9 positive column area. Individual perturbations are compared to non-targeting gRNA control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 100 μm.CC BY · PubMed Central
Extended Data Fig. 12 Perturbations of ASD risk genes lead to enrichment of INPs. a, Confocal images showing immunohistochemical staining of DLX2 on 60-day-old organoids perturbed with individual genes. dTomato labels eCas9-induced cells. b, Bar plot (mean ± S.E.M.; all data points; from left to right, n = 16, 18, 16, 30 areas collected from 4 organoids for each perturbation) showing quantification of the number of DLX2+ cells per 100 μm2 area. Areas containing multiple rosettes from each organoid were collected for quantification. Individual perturbations are compared to non-targeting gRNA control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 500 μm.
Extended Data Fig. 12 Perturbations of ASD risk genes lead to enrichment of INPs. a, Confocal images showing immunohistochemical staining of DLX2 on 60-day-old organoids perturbed with individual genes. dTomato labels eCas9-induced cells. b, Bar plot (mean ± S.E.M.; all data points; from left to right, n = 16, 18, 16, 30 areas collected from 4 organoids for each perturbation) showing quantification of the number of DLX2+ cells per 100 μm2 area. Areas containing multiple rosettes from each organoid were collected for quantification. Individual perturbations are compared to non-targeting gRNA control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 500 μm.CC BY · PubMed Central
Extended Data Fig. 13 Differential expression and GO enrichment analysis of ASD genetic perturbations. a, Scatter plot showing differential expression log fold change in dorsal and ventral telencephalon cells for LEO1 and KMT2C. Dot colour indicates the trajectory where the gene was differentially expressed. b, Bar plot showing perturbation-specific GO enrichment of DEGs in dorsal and ventral telencephalon cells. As a background gene set we used all genes expressed in >5% of cells in the dataset.
Extended Data Fig. 13 Differential expression and GO enrichment analysis of ASD genetic perturbations. a, Scatter plot showing differential expression log fold change in dorsal and ventral telencephalon cells for LEO1 and KMT2C. Dot colour indicates the trajectory where the gene was differentially expressed. b, Bar plot showing perturbation-specific GO enrichment of DEGs in dorsal and ventral telencephalon cells. As a background gene set we used all genes expressed in >5% of cells in the dataset.CC BY · PubMed Central
Extended Data Fig. 14 Quality control and GRN inference from the single-cell multiome dataset. a, Histograms showing UMI count and number of detected features for RNA as well as fragment count and number of detected peaks for ATAC. b, Histogram showing distribution of transcription start site (TSS) enrichment scores across cells. c, Line plot showing TSS enrichment score at each position relative to the TSS. d, Histogram showing distribution of fragment length. e, UMAP embedding showing multiome data (black) integrated with the CHOOSE dataset. Multiome data were used in conjunction with the control cells from the CHOOSE dataset (grey) to infer the GRN with Pando. f, Feature plots showing expression of marker genes on the UMAP embedding. g, Genomic tracks showing accessible peaks in the proximity of GAD2 (ventral marker) and NEUROD6 (dorsal marker). h, Density scatter plot histograms showing the distributions of explained variance (x) and number of variables (y) in the fitted models for GRN construction. Dashed lines indicate the thresholds used for model selection. i, Boxplots showing the distribution of peaks (left) and TFs assigned per gene (middle, n = 864), and number of genes assigned per TF (right, n = 241) in the inferred GRN. The centre line represents the median, the box limits show the 25–75% interquartile range and the whiskers indicate 1.5× the interquartile range. j, Lolliplot showing the enrichment of ASD-associated genes from SFARI in inferred TF modules. Red colour indicates an FDR-corrected two-sided Fisher-test p-value of <0.01. Dot size indicates the total number of genes in the module.
Extended Data Fig. 14 Quality control and GRN inference from the single-cell multiome dataset. a, Histograms showing UMI count and number of detected features for RNA as well as fragment count and number of detected peaks for ATAC. b, Histogram showing distribution of transcription start site (TSS) enrichment scores across cells. c, Line plot showing TSS enrichment score at each position relative to the TSS. d, Histogram showing distribution of fragment length. e, UMAP embedding showing multiome data (black) integrated with the CHOOSE dataset. Multiome data were used in conjunction with the control cells from the CHOOSE dataset (grey) to infer the GRN with Pando. f, Feature plots showing expression of marker genes on the UMAP embedding. g, Genomic tracks showing accessible peaks in the proximity of GAD2 (ventral marker) and NEUROD6 (dorsal marker). h, Density scatter plot histograms showing the distributions of explained variance (x) and number of variables (y) in the fitted models for GRN construction. Dashed lines indicate the thresholds used for model selection. i, Boxplots showing the distribution of peaks (left) and TFs assigned per gene (middle, n = 864), and number of genes assigned per TF (right, n = 241) in the inferred GRN. The centre line represents the median, the box limits show the 25–75% interquartile range and the whiskers indicate 1.5× the interquartile range. j, Lolliplot showing the enrichment of ASD-associated genes from SFARI in inferred TF modules. Red colour indicates an FDR-corrected two-sided Fisher-test p-value of <0.01. Dot size indicates the total number of genes in the module.CC BY · PubMed Central
Extended Data Fig. 15 An ARID1B patient had enlarged ganglionic eminence. a, Graph representation of AR, PBX1, DLX6, OTX2, and OLIG1 TF modules, which are most strongly enriched in ARID1B DEG (Two-sided Fisher exact test p-value < 0.01, top 4 odds ratio). The targets highlighted in yellow are SFARI genes, and the targets highlighted in black are TF modules enriched in SFARI genes. b, Top, sanger sequencing showing a duplication mutation (red arrow) identified in one of the alleles of patient 1. Bottom, sanger sequencing showing the mutation was repaired and this cell line is used as an isogenic control. Sequencing was done on fragments amplified from genomic DNA extracted from the two iPS cell lines. c, SNP array genotyping of PBMCs and iPS cells from patient 2 shows a microdeletion (dark green arrow) identified on chromosome 6. d-f, Bar plot showing the absolute GE (d), cortex (e) and total brain (f) volumes of control (mean ± S.D.; n = 5, age macheted) and patient 2 at two gestational stages. g-h, Bar plots showing normalized GE to cortex volume (g) and total brain volume (h) of control (mean ± S.D.; n = 5, age macheted) and patient 2 at two gestational stages.
Extended Data Fig. 15 An ARID1B patient had enlarged ganglionic eminence. a, Graph representation of AR, PBX1, DLX6, OTX2, and OLIG1 TF modules, which are most strongly enriched in ARID1B DEG (Two-sided Fisher exact test p-value < 0.01, top 4 odds ratio). The targets highlighted in yellow are SFARI genes, and the targets highlighted in black are TF modules enriched in SFARI genes. b, Top, sanger sequencing showing a duplication mutation (red arrow) identified in one of the alleles of patient 1. Bottom, sanger sequencing showing the mutation was repaired and this cell line is used as an isogenic control. Sequencing was done on fragments amplified from genomic DNA extracted from the two iPS cell lines. c, SNP array genotyping of PBMCs and iPS cells from patient 2 shows a microdeletion (dark green arrow) identified on chromosome 6. d-f, Bar plot showing the absolute GE (d), cortex (e) and total brain (f) volumes of control (mean ± S.D.; n = 5, age macheted) and patient 2 at two gestational stages. g-h, Bar plots showing normalized GE to cortex volume (g) and total brain volume (h) of control (mean ± S.D.; n = 5, age macheted) and patient 2 at two gestational stages.CC BY · PubMed Central

Verification

Claims the paper makes

71 Own result · 20 Own method · 20 Own interpretation · 10 Partly supported · 6 Supported · 4 No full text of the sources · 3 Supported so far · 2 No basis given · 1 Not checked yet · accuracy not yet measured

  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 23
  • The quote only partly states this claim. 1
55 of 55
  • The paper relies on this without support.

    CRISPR screens in organoids are limited by low-content readouts, often using guide RNA counts to assess proliferation phenotypes.

    “However, such screens are limited by low-content readouts, which often use guide RNA (gRNA) counts to assess proliferation phenotypes when challenged with genetic perturbations.”
  • The paper relies on this without support.

    CRISPR screening coupled with single-cell transcriptomic readout has not been fully explored in organoids.

    “Although CRISPR screening coupled with single-cell transcriptomic readout provides unprecedented resolution for phenotypic characterization14–16, such approaches have not been fully explored in organoids.”
  • The paper relies on this without support.

    The feasibility of single-cell perturbation screening in heterogeneous tissues that undergo long-term differentiation and consist of diverse cell types remains unclear.

    “The feasibility of single-cell perturbation screening in heterogeneous tissues that undergo long-term differentiation and consist of diverse cell types remains unclear.”
  • The paper relies on this without support.

    Successful genome editing causes frameshift mutations, resulting in loss of blue fluorescent protein fluorescence, enabling quantitative evaluation of guide RNA efficiency.

    “Successful genome editing causes frameshift mutations, resulting in the loss of blue fluorescent protein (BFP) fluorescence, which enables the quantitative evaluation of gRNA efficiency”
  • The paper relies on this without support.

    OLIG1 is preferentially expressed in the ventral telencephalon and is a key regulator for interneuron and oligodendrocyte lineages.

    “Oligodendrocyte transcription factor 1 (OLIG1) is preferentially expressed in the ventral telencephalon and is a key regulator for interneuron and oligodendrocyte lineages.”
  • The paper relies on this without support.

    EOMES is a key transcription factor for the fate specification of intermediate progenitor cells in the dorsal telencephalon.

    “Eomesodermin (EOMES) is a key TF for the fate specification of IPCs in the dorsal telencephalon.”
6 of 6

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 104 references

Cited by

Sorted by citations

See all 283

Metadata

Authors
Li, C., Fleck, J. S., Martins-Costa, C., Burkard, T. R., Themann, J., Stuempflen, M., Peer, A. M., Vertesy, Á., Littleboy, J. B., Esk, C., Elling, U., Kasprian, G., Corsini, N. S., Treutlein, B., & Knoblich, J. A.
Affiliations
  • Institute of Molecular Biotechnology (AT)
  • ETH Zurich (CH)
  • Medical University of Vienna (AT)
Corresponding author
  • Li, Chong
  • Treutlein, Barbara
  • Knoblich, Juergen A.
Venue
Nature
Published
2023-09-13
Volume
621
Issue
7978
Pages
373-380
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4386697296
Cited by
283
References
104
Citations by year
2026: 80 · 2025: 108 · 2024: 74 · 2023: 18
FWCI
20.75
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • National Science Foundation
  • Silicon Valley Community Foundation (CZF2019-002440)
  • Simons Foundation Autism Research Initiative (724430)
  • Boehringer Ingelheim Fonds
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (192604, 310030)
  • Österreichischen Akademie der Wissenschaften (SFB F78)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
autism spectrum disorder, brain organoids, single-cell transcriptomics, cell fate determination, gene regulatory networks, ARID1B, oligodendrocyte precursor cells, excitatory neurons, neurodevelopmental disorders, susceptibility genes
MeSH terms
Autism Spectrum Disorder, Gene Editing, Loss of Function Mutation, CRISPR-Associated Protein 9, Single-Cell Gene Expression Analysis, RNA, Guide, CRISPR-Cas Systems, Autistic Disorder, Brain, Developmental Disabilities, Chromatin, DNA Helicases, DNA-Binding Proteins, Humans, Mosaicism, Neurons, Nuclear Proteins, Organoids, Transcription Factors, Transcription, Genetic, Cell Lineage, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-23, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-23 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review